NEWS
CARE SHOW AND DSDC FIND OUT WHAT DEMENTIA
MEANS TODAY The University of Stirling’s Dementia Services Development Centre (DSDC) has revealed the preliminary results of its global ‘Big Ask’ survey, part of the DSDC’s Dementia Festival of Ideas and undertaken in the lead-up to the International Dementia Conference and Care Show, 3 - 4 November at the NEC, Birmingham.
Across the world, around half (48%) of respondents reported that they now fear dementia more than cancer.
The majority — 63% — considered that those with dementia should be cared for at home while only 11% considered a care home to be the better solution.
The call for a ‘greater public understanding’ is cited as the greatest
OMNICELL UNITES UK BUSINESSES AND OPENS NEW
MANCHESTER HQ Omnicell, Inc. (OMCL), the provider of medication and supply management solutions to the global healthcare market, has announced its plans to consolidate its UK businesses, Surgichem Limited and MTS Medication Technologies.
The company’s headquarters for Europe, the Middle East and Africa is now based in Irlam (Manchester). This move will allow Omnicell to take advantage of Manchester’s strong talent pool and transport networks to support the company’s growth and expansion.
The existing MTS and Surgichem product brands, Easyblist and Nomad, will both be renamed as ‘SureMed® by Omnicell’ over the coming months
- 6 -
contribution to improving the lives of people with dementia (26%).
Professor June Andrews of the DSDC commented: “The ‘Big Ask’ results so far raise some important questions about current approaches to dementia worldwide and what should happen next. What more should be done to address the fear people have of dementia and by whom? What practical steps need to be taken now to ensure more people with dementia can be cared for at home? How can the appetite for understanding be met more effectively?
“We want as many people as possible to help us determine the future of dementia via this powerful and ground-breaking survey. Interestingly, of those actually with dementia who have responded to date, 72% feel they can be useful and contribute to the long-term debate and 81% consider they should be involved in developing policies on dementia. These are worldwide patterns and
there is much more that needs to be done by all of us to make these desired changes happen.”
Launched in April, almost 2,000 people have completed the survey from the UK and over 14 countries across the globe including Australia, Canada, New Zealand, the US and Singapore.
Out of the respondents, 43% were the relative of someone with dementia and 60% were health or care professionals or specialists. A small number are directly affected by dementia.
To complete the survey, please visit
dementia.stir.ac.uk/ideas/big-ask.
www.careshow.co.uk
director for UK & Ireland, commented: “For over 20 years, the mission of Omnicell has been to help improve patient care. It is now widely accepted within the healthcare community that medication adherence is key to delivering better clinical outcomes and cost-efficiencies and Omnicell is tackling the issue of medication non- adherence through innovative solutions.
and will be accompanied by a new visual identity.
Combining the leading multi and single-dose packaging technologies of MTS Medication Technologies with the complementary Surgichem offering is expected to accelerate the development of new medication adherence products and service offerings to benefit healthcare providers and their patients across the world.
Paul O’Hanlon, Omnicell managing
“We believe the bringing together of Surgichem and MTS Medication Technologies under Omnicell UK, coupled with the move to a new state of the art purpose-built headquarters, demonstrates Omnicell’s commitment to the global adherence market,” Mr O’Hanlon added. “This will not only benefit our dedicated and valued employees but will enable us to provide an altogether better service offering to pharmacies, care homes, domiciliary care workers and, ultimately, patients across the world.”
www.omnicell.com
www.tomorrowscare.co.uk
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54